This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Cytokine Levels in Conversion Disorder

This study has been completed.
Information provided by:
Trakya University Identifier:
First received: September 2, 2009
Last updated: October 19, 2010
Last verified: September 2009
The aim of this study is whether the proinflammatory cytokine levels in patients with conversion disorder is increased or not changed in the acute phase and subacute - chronic periode, compared with controls.

Condition Intervention
Conversion Disorder Other: conversion disorder

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Proinflammatory Cytokine Levels in Patients With Conversion Disorder

Resource links provided by NLM:

Further study details as provided by Trakya University:

Estimated Enrollment: 30
Study Start Date: September 2009
Study Completion Date: September 2010
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Conversion disorder Other: conversion disorder
Proinflammatory cytokine levels in conversion disorder
Healthy control Other: conversion disorder
Proinflammatory cytokine levels in conversion disorder


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
primary care clinic

Inclusion Criteria:

  • Clinical diagnosis of Alzheimer's Disease

Exclusion Criteria:

  • Autoimmune disease
  • Neurological disease
  • Any organic disorder that could possibly affect proinflammatory cytokines
  • Pregnancy
  • Any drug usage within 2 weeks
  • Any active or passive immunization within 6 months
  • Any other DSM-IV axis I psychiatric disorder
  • Mental retardation
  • Developmental disorder of childhood
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00971360

Trakya University Faculty of Medicine; Department of Psychiatry
Edirne, Turkey, 22030
Sponsors and Collaborators
Trakya University
  More Information

Responsible Party: Trakya University Scientific Research Unit (TUBAB) Identifier: NCT00971360     History of Changes
Other Study ID Numbers: TUTFEK 2009/173
Study First Received: September 2, 2009
Last Updated: October 19, 2010

Keywords provided by Trakya University:

Additional relevant MeSH terms:
Conversion Disorder
Dissociative Disorders
Pathologic Processes
Somatoform Disorders
Mental Disorders
Histrionic Personality Disorder
Personality Disorders processed this record on September 21, 2017